Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Frequent fried food intake fuels incidence of metabolic associated fatty liver disease attributed to acrylamide-induced hepatic lipid disorders through arachidonic acid-PGE2-PPARα axis.

Journal of advanced research·2026

Same author

Linker Dimensionality Regulation Enabled Isoreticular Extension in Copper-Based Metal-Organic Frameworks for Enhanced CO<sub>2</sub> Adsorption and Hydrocarbon Separation.

Inorganic chemistry·2026

Same author

Marine n-3 fatty acids protect against renal function deterioration in diabetic patients by modulating lipoproteins and promoting cholesterol efflux.

Journal of advanced research·2026

Same author

Effectiveness of AI- and VR-based simulation with traditional teaching in healthcare education: A network meta-analysis.

Nurse education today·2026

Same author

Association of fish oil supplementation with risk of incident severe non-alcoholic fatty liver disease: a prospective study of 488 888 individuals.

Food & function·2026

Same author

Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes.

Cardiovascular diabetology·2026

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Hepatic fibrosis.

Jingjing Jiao¹, Scott L Friedman, Costica Aloman

¹Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

Current Opinion in Gastroenterology

|April 28, 2009

Summary

This summary is machine-generated.

Understanding liver fibrosis progression and resolution is key to developing new therapies. Research highlights the roles of cellular interactions and genetic factors in liver scarring, paving the way for novel treatments.

More Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Area of Science:

Hepatology
Cell Biology
Immunology

Background:

Liver fibrosis arises from an imbalance in extracellular matrix production and degradation.
Cellular crosstalk involving stellate cells, myofibroblasts, and immune cells drives liver scarring following injury.

Purpose of the Study:

To review significant research on liver fibrosis progression and resolution.
To identify emerging therapeutic targets based on current understanding.

Main Methods:

Literature review of key studies in liver fibrosis.
Analysis of cellular and genetic mechanisms underlying fibrosis.

Main Results:

Identified key cellular players including stellate cells, portal myofibroblasts, and bone marrow-derived cells.
Highlighted the importance of growth factors and genetic determinants in fibrosis progression.
Emphasized the complex interactions between various liver cells.

Conclusions:

Improved understanding of stellate cell regulation and activation is crucial.
New therapeutic strategies for liver fibrosis are emerging and validated in preclinical models.